Analysis of the latest quotation and treatment effect of Lenvatinib in 2024
Lenvatinib , as a highly efficient targeted drug, currently plays an important role in the treatment of thyroid cancer and liver cancer. It effectively controls the growth and spread of tumors by precisely inhibiting multiple key tyrosine kinase (RTK) pathways such as vascular endothelial growth factor receptor (VEGFR) and basic fibroblast growth factor receptor (FGFR).
Lenvatinib (Lenvatinib) has been legally marketed in China and has been included in the medical insurance system. Patients can purchase it directly in China. Regarding the price, it is recommended to consult the local pharmacy for the latest information. In addition, foreign original drugs and generic drugs also provide patients with more choices. Especially the quality of Japanese original medicines is guaranteed and the price is about more than one thousand yuan. However, the price of generic drugs in countries such as Laos and Bangladesh is more affordable, about a few hundred yuan, and their efficacy is similar to that of the original drugs.
In the treatment of thyroid cancer, lenvatinib is particularly effective in advanced and refractory cases, especially those whose disease cannot be controlled with surgery or radiation therapy. It inhibits targets such as VEGFR and cuts off the blood supply to tumors, thereby inhibiting their growth. In the treatment of liver cancer, Lenvatinib also performs well, being able to significantly inhibit the proliferation and metastasis of tumor cells and improve the survival of patients.
However, lenvatinib may also cause side effects such as high blood pressure and hand-foot syndrome. Therefore, patients need to closely monitor their physical condition during medication and adjust the dosage as directed by their doctor.
In summary, lenvatinib (Lenvatinib) has demonstrated significant efficacy in the treatment of thyroid cancer and liver cancer with its precise targeting properties, bringing new treatment hope to patients. During the medication process, patients should maintain close communication with their doctors to ensure the safety and effectiveness of the medication.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)